FTSE MIB
34.162,57 -108,55 (-0,32%) Dow Jones
38.460,92 -42,77 (-0,11%) Nasdaq
15.712,75 +16,11 (+0,10%) Nikkei 225
37.628,48 -831,60 (-2,16%) Petrolio
82,93 +0,12 (+0,14%) Bitcoin EUR
59.442,45 -2.496,02 (-4,03%)
Pharming Group N.V. (0QCO.L)
| Chiusura precedente | 0,8083 |
| Aperto | 0,8065 |
| Denaro | N/D x N/D |
| Lettera | N/D x N/D |
| Min-Max giorno | 0,8045 - 0,8090 |
| Intervallo di 52 settimane | 0,6640 - 1,4150 |
| Volume | |
| Media Volume | 1.463.399 |
| Capitalizzazione | 5,014M |
| Beta (5 anni mensile) | 0,74 |
| Rapporto PE (ttm) | 0,54 |
| EPS (ttm) | 0,0150 |
| Prossima data utili | N/D |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswirePharming Group to report third quarter 2023 financial results on October 26
Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023. Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 EDT on October 26, 2023. To participate in the conference call, please register in advance using the link below. Once registered, dial-in informat
- GlobeNewswire
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
Leiden, The Netherlands, September 25, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda. Shareholders approved the appointment of Dr. Richard Peters as Non-Executive director for a period of four years. As a result, Dr. Peters succeeds Mr. Paul Sekhri as Chair of the Board of Directors with immediate effect. Deborah Jorn, Vice-Chair of the
